Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-13

FDA Approved: NABUMETONE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves the original application for Nabumetone as a generic (ANDA) drug manufactured by Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

ORIG AP for NABUMETONE (NABUMETONE)